Osteoporosis, An Issue of Rheumatic Disease Clinics
Seiten
2011
W B Saunders Co Ltd (Verlag)
978-1-4557-7991-8 (ISBN)
W B Saunders Co Ltd (Verlag)
978-1-4557-7991-8 (ISBN)
Explores important topics in the treatment of osteoporosis. This title answers such questions as: How long do I treat my patient? Is there a place for bone turnover markers? And how much Vitamin D should I recommend? It also explores controversies around calcium and Vitamin D regarding the coronary risk and pancreatic issues.
This timely and evocative issue of Rheumatic Disease Clinics explores important current and controversial topics in the treatment of osteoporosis. And it answers some tough questions! Here are some examples. How long do I treat my patient? Is there a place for bone turnover markers? How much Vitamin D should I recommend? Controversies around calcium and Vitamin D are explored regarding the coronary risk and pancreatic issues. Emerging therapies are presented, including sclerostin and oral calcitonin. Long-term safety concerns of antiresporptive therapy (ONJ, atypical fracture, would healing) are explained. The utility and limitations of FRAX are covered, as well as Prolia and the RANKL pathway. An update on glucocorticoid induced OP is given. The reader is also brought up to date on men's health issues and OP. This is an essential issue for any practicing rheumatologist to stay current in the field.
This timely and evocative issue of Rheumatic Disease Clinics explores important current and controversial topics in the treatment of osteoporosis. And it answers some tough questions! Here are some examples. How long do I treat my patient? Is there a place for bone turnover markers? How much Vitamin D should I recommend? Controversies around calcium and Vitamin D are explored regarding the coronary risk and pancreatic issues. Emerging therapies are presented, including sclerostin and oral calcitonin. Long-term safety concerns of antiresporptive therapy (ONJ, atypical fracture, would healing) are explained. The utility and limitations of FRAX are covered, as well as Prolia and the RANKL pathway. An update on glucocorticoid induced OP is given. The reader is also brought up to date on men's health issues and OP. This is an essential issue for any practicing rheumatologist to stay current in the field.
Clinical Professor of Medicine and RheumatologyUCLA / Cedars-Sinai
| Erscheint lt. Verlag | 19.12.2011 |
|---|---|
| Reihe/Serie | The Clinics: Internal Medicine |
| Zusatzinfo | Figures; Tables, black and white |
| Verlagsort | London |
| Sprache | englisch |
| Maße | 152 x 229 mm |
| Gewicht | 370 g |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Rheumatologie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Orthopädie | |
| ISBN-10 | 1-4557-7991-1 / 1455779911 |
| ISBN-13 | 978-1-4557-7991-8 / 9781455779918 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Information für Erkrankte, Angehörige und Betreuende
Buch | Softcover (2023)
Springer (Verlag)
CHF 32,15
Das Wichtigste für Klinik und Praxis
Buch | Softcover (2022)
Urban & Fischer in Elsevier (Verlag)
CHF 49,90
